Algorhythm Holdings, Inc.（納斯達克：RIME）於2026年7月24日提交8-K表格，披露兩項重大事項：

false
 0000923601
 
 
 
 
 
 
 
 0000923601
 
 
 2026-07-21
 2026-07-21
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 iso4217:USD
 
 
 xbrli:shares
 
 
 
 
 

 

 

 

UNITED
STATES

SECURITIES
AND EXCHANGE COMMISSION

Washington,
D.C. 20549

 

FORM
8-K

 

CURRENT
REPORT

Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 
 Date
 of Report (Date of earliest event reported):
 July
 21, 2026

 
 

ALGORHYTHM
HOLDINGS, INC.

 

(Exact
Name of Registrant as Specified in Charter)

 

 
 Delaware
  
 001-41405
  
 95-3795478

 
 (State
 or Other Jurisdiction
  
 (Commission
  
 (IRS
 Employer

 
 of
 Incorporation)
  
 File
 Number)
  
 Identification
 No.)

 
 

 
 6301
 NW 5th Way, Suite 2900
  
  

 
 Fort
 Lauderdale, FL
  
 33309

 
 (Address
 of Principal Executive Offices)
  
 (Zip
 Code)

 
 

 
 Registrant’s
 Telephone Number, Including Area Code:
 (954)
 800-0425

 
 

Not
Applicable

 

(Former
Name or Former Address, if Changed Since Last Report)

 

Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):

 

 
 ☐
 Written
 communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 
  
  

 
 ☐
 Soliciting
 material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 
  
  

 
 ☐
 Pre-commencement
 communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 
  
  

 
 ☐
 Pre-commencement
 communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 

Securities
registered pursuant to Section 12(b) of the Act:

 

 
 Title
 of each class
  
 Trading
 Symbol(s)
  
 Name
 of each exchange on which registered

 
 Common
 Stock, par value $0.01 per share
  
 RIME
  
 The
 Nasdaq Stock Market LLC

 (The
 Nasdaq Capital Market)

 
 

Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging
growth company ☐

 

If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

  

  

 

 

Item
1.01 Entry into a Material Definitive Agreement.

 

On
July 21, 2026, Algorhythm Holdings, Inc. (the “Company”) entered into a settlement agreement and stipulation (the “Settlement
Agreement”) with Continuation Capital, Inc., a Delaware corporation (“CCI”), with respect to certain outstanding liabilities
of the Company in the principal amount of $1,928,014 (the “Claim Amount”) that CCI has acquired from the former holders thereof.

 

Pursuant
to the Agreement, the Company agreed to issue CCI up to 5,000,000 shares of the Company’s common stock, par value $0.01 per share
(the “Shares”), in one or more tranches until CCI has generated aggregate proceeds equal to 120% of the Claim Amount. On
July 23, 2026, the Circuit Court of the Twelfth Judicial Circuit in and for Desoto County, Florida entered an order approving the Settlement
Agreement after a fairness hearing pursuant to Section 3(a)(10) of the Securities Act of 1933, as amended (the “Securities Act”).
The number of shares of common stock held by CCI at any given time cannot exceed 19.99% of the issued and outstanding shares of the Company’s
common stock.

 

The
offer and sale of these securities was and/or will be completed by the Company in private placement transactions that are exempt from
the registration requirements of the Securities Act pursuant to Section 3(a)(10) of the Securities Act without payment of underwriting
discounts or commissions to any person and without engaging in any advertising or general solicitation of any kind.

 

The
foregoing is intended to be a summary of the terms of the Agreement and is subject to and qualified in its entirety by the terms of the
Agreement, a copy of which is attached hereto as Exhibit 10.3.

 

Item
3.02 Unregistered Sales of Equity Securities.

 

The
information contained in Item 1.01 above is incorporated by reference herein.

 

Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

 

On
July 22, 2026, the Company entered into amended and restated employment agreements with: (i) Gary Atkinson, the Company’s Chief
Executive Officer, which agreement supersedes and replaces that certain amended and restated employment agreement entered into with Mr.
Atkinson on February 23, 2026 (the “CEO Agreement”); and (ii) Alex Andre, the Company’s Chief Financial Officer and
General Counsel, which agreement supersedes and replaces that certain employment agreement entered into with Mr. Andre on February 12,
2025 (the “CFO Agreement” and together with the CEO Agreement, the “Employment Agreements”).

 

The
Agreements harmonize the change in control treatment applicable to each of the Company’s executive officers. In furtherance thereof,
each executive officer now has the right to receive a bonus if, and each time, a Change of Control (as defined in the applicable Employment
Agreement) occurs during the term of their employment in a lump sum payment equal to their Base Salary and Annual Bonus (each as defined
in the applicable Employment Agreement) for the year in which the Change of Control occurs. The Employment Agreements also include additional
provisions designed to ensure that various payments that may in the future be made by the Company to the executive officers fully comply
with Sections 280G, 4999 and 409A of the Internal Revenue Code of 1986, as amended.

 

The
foregoing is intended to be a summary of the terms of the Employment Agreements and is subject to and qualified in its entirety by the
terms of the CEO Agreement and CFO Agreement, a copy of each of which is attached hereto as Exhibits 10.1 and 10.2, respectively.

 

Item
9.01 Financial Statement and Exhibits.

 

 
 Exhibit
 No.
  
 Description

 
 10.1
  
 Second Amended and Restated Employment Agreement, dated July 22, 2026, by and between Algorhythm Holdings, Inc. and Gary Atkinson

 
 10.2
  
 Amended and Restated Employment Agreement, dated July 22, 2026, by and between Algorhythm Holdings, Inc. and Alex Andre

 
 10.3*
  
 Settlement Agreement and Stipulation, dated July 21, 2026, by and between Algorhythm Holdings, Inc. and Continuation Capital, Inc.

 
 104
  
 Cover
 Page Interactive Data File (embedded within the Inline XBRL document)

 
 

*
The schedules and exhibits to this agreement have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule
and/or exhibit will be furnished to the SEC upon request.

 

  

  

 

 

SIGNATURE

 

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

 

 
 Date:
 July 24, 2026
 ALGORHYTHM
 HOLDINGS, INC.

 
  
  
  

 
  
 By:
 /s/
 Alex Andre

 
  
 Name:
  Alex
 Andre

 
  
 Title:
  Chief
 Financial Officer and General Counsel